Comment Slightly off topic... (Score 3, Informative) 136
Poor controls mean that antibiotics are leaking out and getting into drinking water. They are in the fish and cattle that we eat, and global travel and exports mean bacteria are traveling.
And those fish, cattle and even people are getting those antibiotics for *free* - seriously impacting our bottom line and tight-fisted control over drugs that, in reality, don't really cost as much as we say they do to research and manufacture, but we sell for a metric fuck-ton of cash.
According to this NY Times article, $2.6 Billion to Develop a Drug? New Estimate Makes Questionable Assumptions are an "estimate that drug companies could have made more money if they used their research investment for things other than drug development."
In both of these announcements, a significant amount of the costs to develop the drugs were opportunity, or time, costs. They are the returns that might be expected, but that investors went without, while a drug was in development. When a drug company invests in research and development, it is tying up money that could otherwise be invested elsewhere. In this announcement, the Tufts Center says that $1.2 billion of the $2.6 billion is time costs.
The end of the article notes:
In 2010, a systematic review of studies that looked at the cost of drug development was published in Health Policy. The review found 13 articles, with estimates ranging from $161 million to $1.8 billion (in 2009 dollars). Obviously, methodology matters.
That's a far cry from $2.6 Billion.